Request a document copy: ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer

Requester name:

Requester e-mail:

Files:

all files (of this document) in restricted access

the file(s) you requested

Message:

Cancel Send